Busulfan, etoposide, cytarabine, and melphalan (BuEAM) as a conditioning regimen for autologous stem cell transplantation in patients with non-Hodgkin lymphoma (NHL)

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Bone marrow transplantation (Basingstoke) 2020-07, Vol.55 (7), p.1466-1468
Hauptverfasser:	Jo, Jae-Cheol, Kim, Jin Seok, Lee, Je-Hwan, Lee, Jung-Hee, Lim, Sung-Nam, Lee, Sang Min, Yoon, Sung-Soo, Kim, In-Ho, Bae, Sung Hwa, Lee, Yoo Jin, Choi, Yunsuk, Lee, Won-Sik
Format:	Artikel
Sprache:	eng
Schlagworte:	631/67/1990/291/1621 692/699/1541/1990/291/1621 Antimitotic agents Antineoplastic agents Autografts Biophysics Busulfan Cell Biology Correspondence Cytarabine Development and progression Etoposide Hematology Immunology Internal Medicine Life Sciences & Biomedicine Lymphoma Lymphomas Medical colleges Medicine Medicine & Public Health Melphalan Non-Hodgkin's lymphoma Oncology Public Health Science & Technology Stem cell transplantation Stem Cells Transplantation
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!